{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+saline", "query": { "intervention": "Control saline" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 2668, "total_pages": 267, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+saline&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-10T09:48:39.204Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03592277", "title": "Vitamin C & Thiamine to Treat Sepsis and Septic Shock", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sepsis", "Septic Shock" ], "interventions": [ { "name": "Vitamin C", "type": "DRUG" }, { "name": "Vitamin B1", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Trinity Health Of New England", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 120, "start_date": "2018-09-14", "completion_date": "2021-02-22", "has_results": true, "last_update_posted_date": "2022-09-28", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 1, "location_summary": "Hartford, Connecticut", "locations": [ { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03592277" }, { "nct_id": "NCT04130464", "title": "Intraperitoneal Infusion of Analgesic for Postoperative Pain Management", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hysterectomy", "Gynecologic Surgical Procedures", "Narcotic Use", "Pain, Postoperative" ], "interventions": [ { "name": "Ropivacaine Infusion from ON-Q Pump", "type": "DRUG" }, { "name": "Ropivacaine + Ketorolac Infusion from ON-Q Pump", "type": "DRUG" }, { "name": "Normal Saline Infusion from ON-Q Pump", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ying Liu", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 120, "start_date": "2019-09-30", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04130464" }, { "nct_id": "NCT05482321", "title": "Pancreas Ultrasound Imaging in type1 Diabetes", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Type1diabetes", "Insulitis", "Pancreas Inflamed" ], "interventions": [ { "name": "Definity Suspension for Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 50, "start_date": "2023-02-27", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05482321" }, { "nct_id": "NCT02722304", "title": "Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Alpha1-antitrypsin Deficiency" ], "interventions": [ { "name": "ARALAST NP 60 mg/kg", "type": "BIOLOGICAL" }, { "name": "ARALAST NP 120 mg/kg", "type": "BIOLOGICAL" }, { "name": "GLASSIA 60 mg/kg", "type": "BIOLOGICAL" }, { "name": "GLASSIA 120 mg/kg", "type": "BIOLOGICAL" }, { "name": "Human Albumin 2%", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Baxalta now part of Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2016-11-02", "completion_date": "2018-09-14", "has_results": true, "last_update_posted_date": "2021-05-13", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 14, "location_summary": "Peoria, Arizona • Newport Beach, California • Kissimmee, Florida + 11 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02722304" }, { "nct_id": "NCT01666652", "title": "A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dengue Fever" ], "interventions": [ { "name": "4 µg TDENV-PIV with Alum adjuvant", "type": "BIOLOGICAL" }, { "name": "1 µg TDENV-PIV with AS03B1 adjuvant", "type": "BIOLOGICAL" }, { "name": "Phosphate buffered saline", "type": "OTHER" }, { "name": "1 µg TDENV-PIV with Alum adjuvant", "type": "BIOLOGICAL" }, { "name": "1 µg TDENV-PIV with AS01E1 adjuvant", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "U.S. Army Medical Research and Development Command", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "ALL", "summary": "18 Years to 39 Years" }, "enrollment_count": 100, "start_date": "2012-09", "completion_date": "2017-11", "has_results": true, "last_update_posted_date": "2019-01-25", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 1, "location_summary": "Silver Spring, Maryland", "locations": [ { "city": "Silver Spring", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01666652" }, { "nct_id": "NCT02697292", "title": "IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Autoimmune Epilepsy" ], "interventions": [ { "name": "Intravenous Immunoglobulin", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 17, "start_date": "2016-02", "completion_date": "2018-12-03", "has_results": true, "last_update_posted_date": "2019-12-30", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02697292" }, { "nct_id": "NCT05831111", "title": "A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Epstein-Barr Virus Infection" ], "interventions": [ { "name": "mRNA-1195.1", "type": "BIOLOGICAL" }, { "name": "mRNA-1195.2", "type": "BIOLOGICAL" }, { "name": "mRNA-1189", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "mRNA-1195", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 482, "start_date": "2023-04-05", "completion_date": "2026-10-13", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 34, "location_summary": "Anniston, Alabama • Tucson, Arizona • Huntington Beach, California + 30 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Longmont", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05831111" }, { "nct_id": "NCT06345833", "title": "Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Hemophilia", "Hemorrhage", "Facelift Surgery" ], "interventions": [ { "name": "1%Tranexamic acid with standard local", "type": "DRUG" }, { "name": "3% TXA", "type": "DRUG" }, { "name": "1% TXA with local plus 3% TXA-soaked pledgets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2024-07-01", "completion_date": "2026-07-01", "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06345833" }, { "nct_id": "NCT00701636", "title": "Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Late Effects of Surgery", "Staphylococcus Aureus", "Surgical Site Infection" ], "interventions": [ { "name": "daptomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "19 Years to 74 Years" }, "enrollment_count": 30, "start_date": "2008-07", "completion_date": "2010-10", "has_results": true, "last_update_posted_date": "2016-08-29", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00701636" }, { "nct_id": "NCT07153614", "title": "Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Perioperative Opioid Sparing Techniques" ], "interventions": [ { "name": "Intrathecal Morphine Block", "type": "PROCEDURE" }, { "name": "Bilateral Quadratus Lumborum Block", "type": "PROCEDURE" }, { "name": "Bilateral Transverse Abdominis Plane Block", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Tennessee Graduate School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 200, "start_date": "2025-02-03", "completion_date": "2027-02-03", "has_results": false, "last_update_posted_date": "2025-09-04", "last_synced_at": "2026-09-10T09:48:39.204Z", "location_count": 1, "location_summary": "Knoxville, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07153614" } ] }